Segment & Geographic Data
Quant-Grade Normalized (live API)
API & CSV Delivery
Tabula Rasa Healthcare Inc's Business Segments
Tabula Rasa Healthcare Inc's reported revenue by business segment and by geographic region, quarterly and annual, normalized against the consolidated income statement. Free below: the top 3 rows per table, this quarter and this fiscal year. Subscriber access adds the full segment history and operating income by segment.
Segment Data As of FY
Reportable Segments
-
Largest Segment
-
Total Revenue
$ 90
Regions Reported
-
Tabula Rasa Healthcare Inc does not report a distinct business-segment axis in its filings - its disaggregated revenue is disclosed by product and service category instead. See the Product & Service breakdown below.
Revenue by Product & Service Category - FY
- Medication77.3%
- Technology Enabled Solutions22.7%
- Value Based Care Solutions17.9%
- Software Subscription and Services4.8%
Revenue by Product & Service Category - FY
| Category | Revenue (Millions) | % of Total |
|---|---|---|
| Medication | $ 70 | 77.3% |
| Technology Enabled Solutions | $ 20 | 22.7% |
| Value Based Care Solutions | $ 16 | 17.9% |
Product and service categories are a supplemental disclosure and are not required to sum to consolidated revenue or to the reportable segments above.
1 more categories available
Sign in to unlock the full Tabula Rasa Healthcare Inc dataset.
Description of Tabula Rasa Healthcare Inc
Tabula Rasa Healthcare Inc. (TRHC) is a publicly traded healthcare technology company specializing in medication management and pharmacy services. The company was founded in 2009 by Calvin H. Knowlton, Ph.D., who is currently the Chairman and CEO.
TRHC's mission is to improve healthcare outcomes for patients and reduce healthcare costs by applying advanced technology and data analytics. The company focuses on medication safety and optimization, medication adherence, and chronic care management for individuals who have multiple chronic conditions.
TRHC's proprietary software platform, MedWise™, utilizes pharmacogenomics, clinical decision support, and medication risk mitigation to provide personalized medication management solutions for patients. The platform is used by healthcare providers, payers, and pharmacists to ensure that patients receive the right medication, at the right dose, at the right time.
TRHC also provides complete medication management services to long-term care facilities and hospice organizations through its CareKinesis® division. This includes medication order review, drug utilization review, and medication dispensing and administration.
In addition to its medication management services, TRHC provides pharmacy benefit management (PBM) services through its Capstone Performance Systems division. This includes pharmacy network management, formulary design, and drug utilization management.
TRHC has grown rapidly over the past decade and currently serves over 300,000 patients nationwide. The company has received numerous awards for its innovative technology and commitment to improving healthcare outcomes, including being recognized as a Top 100 Healthcare IT Company by Becker's Hospital Review.
TRHC is headquartered in Moorestown, New Jersey, and has additional offices and operations throughout the United States. The company's vision is to be the leading provider of technology-enabled healthcare services that optimize medication use and improve patient outcomes.
TRHC's mission is to improve healthcare outcomes for patients and reduce healthcare costs by applying advanced technology and data analytics. The company focuses on medication safety and optimization, medication adherence, and chronic care management for individuals who have multiple chronic conditions.
TRHC's proprietary software platform, MedWise™, utilizes pharmacogenomics, clinical decision support, and medication risk mitigation to provide personalized medication management solutions for patients. The platform is used by healthcare providers, payers, and pharmacists to ensure that patients receive the right medication, at the right dose, at the right time.
TRHC also provides complete medication management services to long-term care facilities and hospice organizations through its CareKinesis® division. This includes medication order review, drug utilization review, and medication dispensing and administration.
In addition to its medication management services, TRHC provides pharmacy benefit management (PBM) services through its Capstone Performance Systems division. This includes pharmacy network management, formulary design, and drug utilization management.
TRHC has grown rapidly over the past decade and currently serves over 300,000 patients nationwide. The company has received numerous awards for its innovative technology and commitment to improving healthcare outcomes, including being recognized as a Top 100 Healthcare IT Company by Becker's Hospital Review.
TRHC is headquartered in Moorestown, New Jersey, and has additional offices and operations throughout the United States. The company's vision is to be the leading provider of technology-enabled healthcare services that optimize medication use and improve patient outcomes.
Tabula Rasa Healthcare Inc is a prominent healthcare technology company specializing in enhancing medication management processes to improve patient care outcomes. The company employs cutting-edge software tools and clinical consulting services that focus on creating personalized medication regimens tailored to the unique needs of individual patients.
Segments:
1. Medication Risk Mitigation:
Tabula Rasa Healthcare Inc prioritizes the reduction of medication-related risks through a robust medication safety platform. This platform seamlessly integrates with electronic health records (EHR) systems and other healthcare IT solutions. The goal is to minimize drug interactions, adverse drug reactions, and other complications associated with medication use. By addressing these risks, the company aims to enhance patient safety and overall health outcomes, fostering a healthcare environment where medication use is closely monitored and adjusted to individual patient profiles.
2. Precision Pharmacotherapy:
Leveraging its proprietary Medication Risk Mitigation technology, the company empowers healthcare providers to make informed, evidence-based medication decisions. This is particularly facilitated by the use of pharmacogenomics tests, which analyze patients genetic information to provide customized drug recommendations. By understanding how patients metabolize different medications based on their genetic profiles, Tabula Rasa helps to eradicate the traditional trial-and-error approach in prescribing medications, thus promoting greater medication adherence and optimal therapeutic results.
Products:
1. MedWise Advisor:
MedWise Advisor serves as Tabula Rasas flagship product, uniquely integrating pharmacogenomics, medication management, and clinical decision support technologies. It functions to optimize medication regimens by alerting healthcare providers to potential risks, such as drug-drug interactions and drug-gene interactions. Through this proactive approach, MedWise Advisor aids providers in ensuring that patients receive safe and effective medication therapy tailored to their specific circumstances.
2. DoseMeRx:
DoseMeRx is an innovative precision dosing tool designed to offer personalized drug dosing recommendations. It employs advanced mathematical modeling to analyze patients’ clinical and demographic data, ensuring that dosing regimens are accurately tailored to achieve therapeutic goals. This tool is particularly beneficial in managing the care of critically ill patients, where achieving the correct dosage is crucial for avoiding adverse drug events and ensuring effective treatment.
Services:
1. Medication Regimen Review:
The company offers comprehensive medication regimen review services, wherein expert teams conduct an in-depth assessment of patients current medication therapies. This review scrutinizes medication histories, identifies potential drug interactions, mitigates adverse drug events, and evaluates overall medication-related risks. By conducting these thorough reviews, Tabula Rasa helps healthcare providers enhance the safety and efficacy of their prescribing practices.
2. Pharmacogenomics Testing:
Tabula Rasa Healthcare Inc provides pharmacogenomics testing services that investigate patients genetic profiles. This testing identifies genetic variants that influence how individuals metabolize various drugs, allowing for more informed and personalized medication decisions. By providing healthcare providers with insights into how a patient is likely to respond to certain medications, these services contribute significantly to creating safer and more effective treatment plans.
Summary:
In essence, Tabula Rasa Healthcare Inc stands at the forefront of medication management innovation, equipping healthcare providers with the necessary tools and services to enhance patient safety and treatment effectiveness. Through its focus on medication risk mitigation and precision pharmacotherapy, alongside its flagship products—MedWise Advisor and DoseMeRx—and its comprehensive suite of services, including medication regimen reviews and pharmacogenomics testing, the company is dedicated to delivering a high standard of personalized care for patients across various healthcare settings.
Segments:
1. Medication Risk Mitigation:
Tabula Rasa Healthcare Inc prioritizes the reduction of medication-related risks through a robust medication safety platform. This platform seamlessly integrates with electronic health records (EHR) systems and other healthcare IT solutions. The goal is to minimize drug interactions, adverse drug reactions, and other complications associated with medication use. By addressing these risks, the company aims to enhance patient safety and overall health outcomes, fostering a healthcare environment where medication use is closely monitored and adjusted to individual patient profiles.
2. Precision Pharmacotherapy:
Leveraging its proprietary Medication Risk Mitigation technology, the company empowers healthcare providers to make informed, evidence-based medication decisions. This is particularly facilitated by the use of pharmacogenomics tests, which analyze patients genetic information to provide customized drug recommendations. By understanding how patients metabolize different medications based on their genetic profiles, Tabula Rasa helps to eradicate the traditional trial-and-error approach in prescribing medications, thus promoting greater medication adherence and optimal therapeutic results.
Products:
1. MedWise Advisor:
MedWise Advisor serves as Tabula Rasas flagship product, uniquely integrating pharmacogenomics, medication management, and clinical decision support technologies. It functions to optimize medication regimens by alerting healthcare providers to potential risks, such as drug-drug interactions and drug-gene interactions. Through this proactive approach, MedWise Advisor aids providers in ensuring that patients receive safe and effective medication therapy tailored to their specific circumstances.
2. DoseMeRx:
DoseMeRx is an innovative precision dosing tool designed to offer personalized drug dosing recommendations. It employs advanced mathematical modeling to analyze patients’ clinical and demographic data, ensuring that dosing regimens are accurately tailored to achieve therapeutic goals. This tool is particularly beneficial in managing the care of critically ill patients, where achieving the correct dosage is crucial for avoiding adverse drug events and ensuring effective treatment.
Services:
1. Medication Regimen Review:
The company offers comprehensive medication regimen review services, wherein expert teams conduct an in-depth assessment of patients current medication therapies. This review scrutinizes medication histories, identifies potential drug interactions, mitigates adverse drug events, and evaluates overall medication-related risks. By conducting these thorough reviews, Tabula Rasa helps healthcare providers enhance the safety and efficacy of their prescribing practices.
2. Pharmacogenomics Testing:
Tabula Rasa Healthcare Inc provides pharmacogenomics testing services that investigate patients genetic profiles. This testing identifies genetic variants that influence how individuals metabolize various drugs, allowing for more informed and personalized medication decisions. By providing healthcare providers with insights into how a patient is likely to respond to certain medications, these services contribute significantly to creating safer and more effective treatment plans.
Summary:
In essence, Tabula Rasa Healthcare Inc stands at the forefront of medication management innovation, equipping healthcare providers with the necessary tools and services to enhance patient safety and treatment effectiveness. Through its focus on medication risk mitigation and precision pharmacotherapy, alongside its flagship products—MedWise Advisor and DoseMeRx—and its comprehensive suite of services, including medication regimen reviews and pharmacogenomics testing, the company is dedicated to delivering a high standard of personalized care for patients across various healthcare settings.